Narinée Hovhannisyan‐Baghdasarian

Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancer

Nicolas Captier, Marvin Lerousseau, Fanny Orlhac et al. · Nature Communications · 2025 · 50 citations · Full text

Medicine, Immunology, Oncology +17

Comparative Analysis between [¹⁸F]Fludarabine-PET and [¹⁸F]FDG-PET in a Murine Model of Inflammation

Narinée Hovhannisyan‐Baghdasarian, Martine Dhilly, Stéphane Guillouet et al. · Molecular Pharmaceutics · 2016 · 15 citations

Medicine, Nuclear Medicine, Inflammation +13

Promising Candidate Prognostic Biomarkers in [¹⁸F]FDG PET Images: Evaluation in Independent Cohorts of Non–Small Cell Lung Cancer Patients

Narinée Hovhannisyan‐Baghdasarian, Marie Luporsi, Nicolas Captier et al. · Journal of Nuclear Medicine · 2024 · 15 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Measuring Total Metabolic Tumor Volume from¹⁸F-FDG PET: A Reality Check

Ronald Boellaard, Gerben J.C. Zwezerijnen, Irène Buvat et al. · Journal of Nuclear Medicine · 2025 · 11 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

[18F]Fludarabine-PET in a murine model of multiple myeloma

Narinée Hovhannisyan‐Baghdasarian, Martine Dhilly, Martin Fidalgo et al. · PLoS ONE · 2017 · 10 citations · Full text

Medicine, Hematology, Nuclear Medicine +17